Reading MNKD? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MNKD free→Reading MNKD? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MNKD free→QuarterlyIQ Insights · MNKD
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On May 6, 2026, MannKind Corporation issued a press release, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
Results of Operations and Financial Condition. On February 26, 2026, MannKind Corporation issued a press release, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
Results of Operations and Financial Condition. On November 5, 2025, MannKind Corporation issued a press release, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
Entry into a Material Definitive Agreement. On August 24, 2025 MannKind Corporation (“MannKind”) entered into a first amendment (“First Amendment”) to the global license and collaboration agreement dated September 3, 2018 (the “License Agreement”) with United Therapeutics Corporation (“United Therapeutics”). The First Amendment memorializes the exercise of United Therapeutics’ option to expand the scope of the products covered by the License Agreement to include an additional development prod…
Entry into a Material Definitive Agreement. Agreement and Plan of Merger On August 24, 2025, MannKind Corporation, a Delaware corporation (“ Parent ”), Seacoast Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent (“ Purchaser ”), and scPharmaceuticals Inc., a Delaware corporation (the “ Target ”), entered into a definitive Agreement and Plan of Merger (the “ Merger Agreement ”), pursuant to which Parent, through Purchaser, will commence a tender offer (the…
or Exhibits 99.1 and 99.2 . Forward-Looking Statements This report contains forward-looking statements. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans”, “will”, “goal” and similar expressions. These forward-looking statements include, without limitation, statements related to the proposed Offer, Merger and related transactions contemplated by the Merger Agreement and the CVR Agreement and the expected timin…
Results of Operations and Financial Condition. On August 6, 2025, MannKind Corporation issued a press release, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) (e) On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company. On May 14, 2025, the Company and Mr. Blank entered into a transition and separation agreemen…
Results of Operations and Financial Condition. On May 8, 2025, MannKind Corporation issued a press release, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
Results of Operations and Financial Condition. On February 26, 2025, MannKind Corporation issued a press release, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.